Dose Tapering and Early Discontinuation to InCreAse cosT-effectIveness Of Immunotherapy for NSCLC
Clinical trial NCT04909684 · UNKNOWN
Trial details
- NCT number
- NCT04909684
- Sponsor
- Radboud University Medical Center
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2024-11-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.